Practus delivers 5x-10x ROI for Pharma clients through outcome focused transformation

Mumbai, 17th Sept – Practus, a leading ROI driven business consulting firm, is driving measurable EBITDA growth for pharmaceutical companies through execution-led, technology-enabled transformation.
Margin pressures are squeezing India’s pharma sector, with even industry leaders reporting steep profit declines despite revenue growth. Rising raw material costs, regulatory complexities and global competition mean incremental fixes no longer suffice and end-to-end transformation has become essential to protect margins and sustain growth.
Practus partners with pharma companies to unlock ROI across the value chain – sourcing, procurement, planning, manufacturing and sales and distribution. Its proven approach includes alternate vendor development, price benchmarking, cycle time reduction, batch quality improvements, reduction in manufacturing overheads, OTIF improvement, inventory optimization, network footprint rationalization, and sales force effectiveness. Practus’ execution and ROI focus enables faster decision-making, stronger data visibility, and builds scalable, digital-first processes that directly impact EBITDA.
Tangible Results
Practus’ outcome focussed interventions have consistently delivered:
4%-9% reduction in direct material costs
7%–17% reduction in indirect spend
15%–20% improvement in throughput
15%–20% improvement in customer OTIFs
10%–20% reduction in inventory
10%–50% revenue growth
One of India’s leading API manufacturing companies faced long production lead times, fluctuating demand, and high costs. Practus implemented value stream mapping, KPI-driven analysis, DMAIC improvement projects, and capability-building initiatives leading to:
10–15% improvement in throughput
30–50% reduction in backorders
5–15% increase in capacity utilization
5–10% reduction in changeover time
~10% improvement in manpower productivity
Over 150 hours manhours of training helped create a Centre of Excellence (COE) for sustained operational excellence. The engagement not only resolved immediate bottlenecks but also scalable growth and global competitiveness.
“Pharma companies today can’t afford inefficiencies. Rising costs, global competition, and compliance complexities demand precision and speed,” said Shashank Silhare, Engagement Partner – Practus “We combine deep domain expertise along with capabilities in automation and digital tools we help clients unlock significant EBITDA gains – not just short-term savings, but lasting ROI.”